跳至主要内容
临床试验/NCT03497234
NCT03497234撤回不适用

Development of a Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test to Detect Intra-Amniotic Infection and Predict Preterm Birth in Women Presenting With Preterm Labor and Intact Amniotic Membranes

Hologic, Inc.10 个研究点 分布在 1 个国家开始时间: 2018年3月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
发起方
Hologic, Inc.
试验地点
10
主要终点
performance of vaginal fluid test

研究概览

简要总结

A multi-centered, prospective study, involving pregnant women presenting to the labor and delivery unit of collaborating clinical study sites with preterm labor and intact amniotic membranes with and without suspected Intra-Amniotic Infection (IAI).

详细描述

A study on patients in preterm labor for whom the managing physician plans to perform amniocentesis to evaluate for possible infection using conventional, currently available methods. Vaginal fluid will be collected and analyzed and amniotic fluid will also. These tests will be run remotely and not reported to the clinician.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

盲法说明

Investigator is blinded to results of the analyzer but all patients have samples run on analyzer

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is ≥ 18 years of age
  • Subject has singleton gestation
  • Subject has fetus with gestational age ≥ 22 0/7 weeks and ≤ 33 6/7 weeks
  • Subject has had evidence of spontaneous preterm labor as evidenced by documented regular uterine contractions (≥4 per hour) and one or more of the following:
  • Cervical dilation > 2cm
  • Cervical length of ≤25 mm via transvaginal ultrasound
  • Subject has onset of contractions was within 48 hours of enrollment in the study
  • Subject has documented intact amniotic membranes
  • Subject's care provider plans to perform an amniocentesis procedure -

排除标准

  • Subject has documented ruptured amniotic membranes
  • Subject has a fetus with major fetal or genetic anomaly or chromosomal aneuploidy
  • Subject has maternal or fetal indication for preterm birth (e.g., pre-eclampsia)
  • Subject is unable to provide written informed consent
  • Subject has evidence of non-reassuring fetal heart rate tracing requiring immediate delivery
  • Subject has vaginal bleeding within the past 24 hours
  • Subject has advanced labor (cervix >4 cm dilated)
  • Subject has HIV, hepatitis
  • Subject has not been enrolled previously in this study and/or is participating in another study (that in the opinion of the Investigator) may interfere with participation in this study

研究组 & 干预措施

All women eligible to participate

Experimental

All women presenting who sign the consent and found eligible will have a VF and AF sample taken and analyzed on the Perilynx Analyzer to measure AF and VF fluid. This does not affect their regular standard of care and diagnosis

干预措施: Perilynx Analyzer to measure AF and VF fluid (Diagnostic Test)

结局指标

主要结局

performance of vaginal fluid test

时间窗: 18 months

To assess the performance of a vaginal fluid test for assessing risk of IAI in subjects presenting with preterm labor and intact membranes.

performance of amniocentesis test

时间窗: 18 months

To assess the performance of a rapid amniotic fluid test to identify intraamniotic infection (IAI).

次要结局

未报告次要终点

研究者

发起方
Hologic, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验

Rapid Amniotic Fluid (AF) Test and a Non-Invasive... | 临床试验